Alkem Labs Q2 Net up 14 percent at Rs 327.44 crore Ruby Khatun Khatun11 Nov 2017 10:16 AM ISTNew Delhi: Drug firm Alkem Laboratories reported a 13.63 percent rise in consolidated net profit at Rs 327.44 crore for the quarter ended September 30...
FDA OKs Merck drug that prevents infection post-stem cell transplant Ruby Khatun Khatun11 Nov 2017 10:01 AM ISTMerck & Co Ltd's drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug...
Dynavax hepatitis B vaccine gets FDA nod on third try, shares up Ruby Khatun Khatun11 Nov 2017 9:45 AM ISTDynavax Technologies Corp's hepatitis B vaccine won the U.S. Food and Drug Administration's approval on the third attempt and Chief Executive Eddie...
Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales Ruby Khatun Khatun11 Nov 2017 9:30 AM ISTRegeneron Pharmaceuticals Inc on Wednesday reported third-quarter profit that sailed past Wall Street estimates on the strength of increased demand...
Novartis takes fight to Pfizers Ibrance with new Kisqali data Ruby Khatun Khatun10 Nov 2017 10:17 AM ISTZURICH: New data from Novartis's breast cancer drug Kisqali underscored its effectiveness in pre-menopausal women, the Swiss drugmaker said, amid...
GSK appoints scientist Barron as new Research and Development head Ruby Khatun Khatun10 Nov 2017 9:47 AM ISTLONDON: GlaxoSmithKline (GSK) has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head as new Chief...
MORE DRUGS added to the Schedule H list Ruby Khatun Khatun9 Nov 2017 11:38 AM ISTThrough a recent gazette notification, Ministry of Health And Family Welfare has extended the list of schedule H drugs by adding more drugs to...
Mylan seeks EMA approval for 2 biosimilars Ruby Khatun Khatun9 Nov 2017 10:32 AM ISTNew Delhi: Biocon said that its partner Mylan has re-submitted marketing authorization applications with the European Medicines Agency for two...
Alembic Pharma Q2 net rises over 1 percent to Rs 121 crore Ruby Khatun Khatun9 Nov 2017 10:16 AM ISTNew Delhi: Alembic Pharmaceuticals reported a 1.44 percent increase in consolidated net profit at Rs 121.56 crore for the second quarter ended...
Mallinckrodt dives as sales of main drug Acthar disappoint Ruby Khatun Khatun9 Nov 2017 9:37 AM ISTShares of Mallinckrodt Plc plunged more than 30 percent to an all-time low on Tuesday after the drugmaker reported disappointing quarterly revenue and...
US senators press Allergan for details on patent deal with tribe Ruby Khatun Khatun9 Nov 2017 9:15 AM ISTA group of U.S. senators on Tuesday asked drugmaker Allergan Plc to produce documents relating to its agreement to transfer patents to a Native...
FDA approves intravenous version of Tesaro drug for chemotherapy nausea Ruby Khatun Khatun28 Oct 2017 9:44 AM ISTTesaro Inc said on Wednesday that the U.S. Food and Drug Administration (FDA) approved an intravenous version of its drug to treat...
